BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 18656824)

  • 1. Histological assessment of oesophageal columnar mucosa.
    Flejou JF
    Best Pract Res Clin Gastroenterol; 2008; 22(4):671-86. PubMed ID: 18656824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barrett's oesophagus--a pathologist's view.
    Fléjou JF; Svrcek M
    Histopathology; 2007 Jan; 50(1):3-14. PubMed ID: 17204017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barrett's oesophagus: from metaplasia to dysplasia and cancer.
    Fléjou JF
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i6-12. PubMed ID: 15711008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of the neosquamous epithelium after radiofrequency ablation of Barrett's esophagus containing neoplasia.
    Pouw RE; Gondrie JJ; Rygiel AM; Sondermeijer CM; ten Kate FJ; Odze RD; Vieth M; Krishnadath KK; Bergman JJ
    Am J Gastroenterol; 2009 Jun; 104(6):1366-73. PubMed ID: 19491850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoplastic precursor lesions in Barrett's esophagus.
    Hornick JL; Odze RD
    Gastroenterol Clin North Am; 2007 Dec; 36(4):775-96, v. PubMed ID: 17996790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk estimation in Barrett's esophagus: biomolecular marker and histopathologic classification].
    Walch A; Schmitt-Gräff A; Stein H; Werner M
    Zentralbl Chir; 2002 Dec; 127(12):1073-7. PubMed ID: 12529823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Barrett's esophagus: endoscopic treatment of high-grade dysplasia and early cancer].
    Bergman JJ; Marsman WA; Krishnadath KK; Fockens P; van Lanschot JJ; Tytgat GN
    Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2275-81. PubMed ID: 14655293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a prospective multicenter study.
    Sharma P; Marcon N; Wani S; Bansal A; Mathur S; Sampliner R; Lightdale C
    Endoscopy; 2006 Dec; 38(12):1206-12. PubMed ID: 17163320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic approaches to Barrett's oesophagus with high-grade dysplasia/early mucosal cancer.
    Ginsberg GG
    Best Pract Res Clin Gastroenterol; 2008; 22(4):751-72. PubMed ID: 18656828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer risk in Barrett's oesophagus.
    Dias Pereira A; Suspiro A; Chaves P
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):915-8. PubMed ID: 18049157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetic acid-enhanced magnification endoscopy in the diagnosis of specialized intestinal metaplasia, dysplasia and early cancer in Barrett's oesophagus.
    Fortun PJ; Anagnostopoulos GK; Kaye P; James M; Foley S; Samuel S; Shonde A; Badreldin R; Campbell E; Hawkey CJ; Ragunath K
    Aliment Pharmacol Ther; 2006 Mar; 23(6):735-42. PubMed ID: 16556175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: prevalence of Barrett's oesophagus and metaplasia at the gastro-oesophageal junction.
    Sharma P
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():48-54; discussion 61-2. PubMed ID: 15456464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
    Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
    Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New developments in the endoscopic surveillance of Barrett's oesophagus.
    Bergman JJ; Tytgat GN
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i38-42. PubMed ID: 15711007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barrett's esophagus.
    Bonino JA; Sharma P
    Curr Opin Gastroenterol; 2005 Jul; 21(4):461-5. PubMed ID: 15930989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histology of metaplasia and dysplasia in Barrett's esophagus.
    Yerian L
    Surg Oncol Clin N Am; 2009 Jul; 18(3):411-22. PubMed ID: 19500733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Barrett carcinoma--diagnosis, screening, surveillance, endoscopic treatment, prevention].
    Peitz U; Malfertheiner P
    Z Gastroenterol; 2007 Dec; 45(12):1264-72. PubMed ID: 18080229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of computed virtual chromoendoscopy and conventional chromoendoscopy with acetic acid for detection of neoplasia in Barrett's esophagus.
    Pohl J; May A; Rabenstein T; Pech O; Nguyen-Tat M; Fissler-Eckhoff A; Ell C
    Endoscopy; 2007 Jul; 39(7):594-8. PubMed ID: 17611913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A surveillance programme for Barrett's oesophagus in a UK general hospital.
    Olithselvan A; Gorard DA; McIntyre AS
    Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):305-9. PubMed ID: 17353694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.